• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德岛大学医院广泛期小细胞肺癌患者的预后因素分析

Analysis of the Prognostic Factors of Extensive Disease Small-Cell Lung Cancer Patients in Tokushima University Hospital.

作者信息

Ogino Hirokazu, Hanibuchi Masaki, Kakiuchi Soji, Saijo Atsuro, Tezuka Toshifumi, Toyoda Yuko, Tobiume Makoto, Otsuka Kenji, Sakaguchi Satoshi, Goto Hisatsugu, Arisawa Kokichi, Nishioka Yasuhiko

机构信息

Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University.

出版信息

J Med Invest. 2016;63(3-4):286-93. doi: 10.2152/jmi.63.286.

DOI:10.2152/jmi.63.286
PMID:27644574
Abstract

BACKGROUND

Small-cell lung cancer (SCLC) presents aggressive clinical behavior, and its prognosis is still poor. Previously, performance status (PS), or the existence of brain, bone, or liver metastasis were reported to be unfavorable prognostic factors. Given the recent progress of treatment modalities such as radiotherapy techniques and bone modifying agents, the prognostic factors might be different from previous findings. Therefore, we analyzed the prognostic factors of extensive disease SCLC (ED-SCLC) in recent years.

METHODS

ED-SCLC patients treated in Tokushima University Hospital between 2010 and 2016 were analyzed. Log-rank test and the Cox proportional hazards regression model was used in univariate and multivariate analysis, respectively.

RESULTS

Totally, 79 patients were analyzed. In the univariate analysis, age, PS, interstitial pneumonia (IP), liver metastasis, pleural dissemination, neutrophil counts, hypoalbuminemia, hypercalcemia and several liver and biliary enzymes were identified as poor prognostic factors. In the multivariate analysis, age, PS, IP, and liver and biliary enzymes were identified. Moreover, the PS in patients with liver metastasis was significantly worsened.

CONCLUSIONS

In this study, we newly demonstrated that IP was a significant poor prognostic factor of ED-SCLC. Although liver metastasis was not extracted in multivariate analysis, it may have an impact on the prognosis of ED-SCLC. J. Med. Invest. 63: 286-293, August, 2016.

摘要

背景

小细胞肺癌(SCLC)具有侵袭性临床行为,其预后仍然很差。此前,据报道,体能状态(PS)或存在脑、骨或肝转移是不良预后因素。鉴于放疗技术和骨改良剂等治疗方式的最新进展,预后因素可能与先前的研究结果不同。因此,我们分析了近年来广泛期小细胞肺癌(ED-SCLC)的预后因素。

方法

分析了2010年至2016年在德岛大学医院接受治疗的ED-SCLC患者。分别采用对数秩检验和Cox比例风险回归模型进行单因素和多因素分析。

结果

共分析了79例患者。在单因素分析中,年龄、PS、间质性肺炎(IP)、肝转移、胸膜播散、中性粒细胞计数、低白蛋白血症、高钙血症以及几种肝和胆汁酶被确定为不良预后因素。在多因素分析中,确定了年龄、PS、IP以及肝和胆汁酶。此外,肝转移患者的PS显著恶化。

结论

在本研究中,我们首次证明IP是ED-SCLC的一个显著不良预后因素。尽管在多因素分析中未提取到肝转移,但它可能对ED-SCLC的预后有影响。《医学调查杂志》63: 286 - 293,2016年8月。

相似文献

1
Analysis of the Prognostic Factors of Extensive Disease Small-Cell Lung Cancer Patients in Tokushima University Hospital.德岛大学医院广泛期小细胞肺癌患者的预后因素分析
J Med Invest. 2016;63(3-4):286-93. doi: 10.2152/jmi.63.286.
2
Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity.广泛期小细胞肺癌(ED-SCLC)生存的预后因素:吸烟史、社会经济和婚姻状况以及种族的重要性。
J Thorac Oncol. 2009 Jan;4(1):37-43. doi: 10.1097/JTO.0b013e31819140fb.
3
Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.影响广泛期小细胞肺癌胸内进展风险的预后因素。
BMC Cancer. 2016 Mar 8;16:197. doi: 10.1186/s12885-016-2222-4.
4
Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia.间质性肺炎广泛期小细胞肺癌患者细胞毒化疗的疗效和风险。
BMC Cancer. 2019 Feb 20;19(1):163. doi: 10.1186/s12885-019-5367-0.
5
The prognostic factors in the elderly patients with small cell lung cancer: a retrospective analysis from a single cancer institute.老年小细胞肺癌患者的预后因素:来自单一癌症研究所的回顾性分析。
Int J Clin Exp Pathol. 2015 Sep 1;8(9):11033-41. eCollection 2015.
6
Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.小细胞肺癌的预后因素因肿瘤分期而异:北中部癌症治疗组试验的汇总分析
Cancer. 2009 Jun 15;115(12):2721-31. doi: 10.1002/cncr.24314.
7
Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.广泛期小细胞肺癌患者接受培美曲塞加卡铂与依托泊苷加卡铂治疗的预后因素:基线生活质量和体能状态。
Lung Cancer. 2012 Dec;78(3):276-81. doi: 10.1016/j.lungcan.2012.09.002. Epub 2012 Oct 6.
8
Prognostic significance of body mass index and serum albumin as the indicators of nutritional status in small cell lung cancer.体质量指数和血清白蛋白作为小细胞肺癌营养状况指标的预后意义。
Postgrad Med. 2024 Mar;136(2):208-217. doi: 10.1080/00325481.2024.2328512. Epub 2024 Mar 12.
9
NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.NAD(P)H:醌氧化还原酶 1 过表达预示小细胞肺癌预后不良。
Oncol Rep. 2014 Dec;32(6):2589-95. doi: 10.3892/or.2014.3494. Epub 2014 Sep 17.
10
Hypoxia-inducible factor-1α and excision repair cross-complementing 1 in patients with small cell lung cancer who received front-line platinum-based chemotherapy: a retrospective study.缺氧诱导因子-1α 和修复交叉互补基因 1 在接受一线铂类化疗的小细胞肺癌患者中的表达:一项回顾性研究。
J Thorac Oncol. 2012 Mar;7(3):528-34. doi: 10.1097/JTO.0b013e3182417830.

引用本文的文献

1
Model development and validation for predicting small-cell lung cancer bone metastasis utilizing diverse machine learning algorithms based on the SEER database.基于监测、流行病学和最终结果(SEER)数据库,利用多种机器学习算法预测小细胞肺癌骨转移的模型开发与验证
Medicine (Baltimore). 2025 Mar 21;104(12):e41987. doi: 10.1097/MD.0000000000041987.
2
Trends in Epidemiology and Outcome of Small Cell Lung Cancer over 10 Years at Tertiary Cancer Care Center in Iran.伊朗三级癌症护理中心10年间小细胞肺癌的流行病学趋势及治疗结果
Tanaffos. 2023 Apr;22(4):411-417.
3
CAMSAP1 Mutation Correlates With Improved Prognosis in Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy.
CAMSAP1突变与接受铂类化疗的小细胞肺癌患者预后改善相关。
Front Cell Dev Biol. 2022 Jan 11;9:770811. doi: 10.3389/fcell.2021.770811. eCollection 2021.
4
High mutations in fatty acid metabolism contribute to a better prognosis of small-cell lung cancer patients treated with chemotherapy.脂肪酸代谢中的高突变有助于改善接受化疗的小细胞肺癌患者的预后。
Cancer Med. 2021 Nov;10(21):7863-7876. doi: 10.1002/cam4.4290. Epub 2021 Sep 26.
5
Paclitaxel for treatment of advanced small cell lung cancer (SCLC): a retrospective study of 185 patients.紫杉醇治疗晚期小细胞肺癌(SCLC):185例患者的回顾性研究
J Thorac Dis. 2020 Mar;12(3):782-793. doi: 10.21037/jtd.2019.12.74.
6
mutation correlates with cisplatin sensitivity and tumor mutation burden in small-cell lung cancer.突变与小细胞肺癌中顺铂敏感性和肿瘤突变负担相关。
Aging (Albany NY). 2020 Jan 20;12(2):1285-1303. doi: 10.18632/aging.102683.
7
A novel mutation panel for predicting etoposide resistance in small-cell lung cancer.一种用于预测小细胞肺癌中依托泊苷耐药性的新型突变检测板。
Drug Des Devel Ther. 2019 Jun 21;13:2021-2041. doi: 10.2147/DDDT.S205633. eCollection 2019.
8
Clinical factors associated with the therapeutic outcome of chemotherapy in very elderly cancer patients.与高龄癌症患者化疗治疗效果相关的临床因素。
Int J Clin Oncol. 2019 May;24(5):596-601. doi: 10.1007/s10147-018-01385-8. Epub 2019 Jan 3.
9
Prognostic effects of osteoclast inhibitors in extensive stage small cell lung cancer patients with bone metastases.破骨细胞抑制剂对广泛期小细胞肺癌骨转移患者的预后影响。
Mol Clin Oncol. 2018 Nov;9(5):561-565. doi: 10.3892/mco.2018.1710. Epub 2018 Sep 4.